Search research articles
Contact Us
Filters
Showing results (71-80 of 105) with videos related to
Page
of 11
Sort By:
Transplantation Proceedings
|
February 11, 2014
Improvement in gastrointestinal and health-related quality of life outcomes after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant recipients
M Sterneck, U Settmacher, T Ganten, et al.
Journal of Viral Hepatitis
|
December 17, 2013
Impact of ribavirin priming on viral kinetics and treatment response in chronic hepatitis C genotype 1 infection
U Mihm, M-W Welker, G Teuber, et al.
Journal of Viral Hepatitis
|
June 20, 2007
Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases
W P Hofmann, B Fernandez, E Herrmann, et al.
Alimentary Pharmacology & Therapeutics
|
August 24, 2016
The efficacy and safety of direct acting antiviral treatment and clinical significance of drug-drug interactions in elderly patients with chronic hepatitis C virus infection
J Vermehren, K-H Peiffer, C Welsch, et al.
Journal of Viral Hepatitis
|
September 3, 2008
Expert opinion on the treatment of patients with chronic hepatitis C
S Zeuzem, T Berg, B Moeller, et al.
Journal of Viral Hepatitis
|
January 14, 2012
Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b
J Vermehren, S Susser, C M Lange, et al.
Journal of Viral Hepatitis
|
August 5, 2008
Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy
W P Hofmann, B Kronenberger, J Bojunga, et al.
Alimentary Pharmacology & Therapeutics
|
June 20, 2017
No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort
V T Mücke, M M Mücke, K-H Peiffer, et al.
Journal of Viral Hepatitis
|
August 9, 2016
Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy
V Knop, D Hoppe, T Welzel, et al.
Medical Microbiology and Immunology
|
December 16, 2015
Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment
F Wiesmann, G Naeth, A Berger, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 105) with videos related to
Sort By:
Page
of 11
Transplantation Proceedings
|
February 11, 2014
Improvement in gastrointestinal and health-related quality of life outcomes after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant recipients
M Sterneck, U Settmacher, T Ganten, et al.
Journal of Viral Hepatitis
|
December 17, 2013
Impact of ribavirin priming on viral kinetics and treatment response in chronic hepatitis C genotype 1 infection
U Mihm, M-W Welker, G Teuber, et al.
Journal of Viral Hepatitis
|
June 20, 2007
Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases
W P Hofmann, B Fernandez, E Herrmann, et al.
Alimentary Pharmacology & Therapeutics
|
August 24, 2016
The efficacy and safety of direct acting antiviral treatment and clinical significance of drug-drug interactions in elderly patients with chronic hepatitis C virus infection
J Vermehren, K-H Peiffer, C Welsch, et al.
Journal of Viral Hepatitis
|
September 3, 2008
Expert opinion on the treatment of patients with chronic hepatitis C
S Zeuzem, T Berg, B Moeller, et al.
Journal of Viral Hepatitis
|
January 14, 2012
Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b
J Vermehren, S Susser, C M Lange, et al.
Journal of Viral Hepatitis
|
August 5, 2008
Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy
W P Hofmann, B Kronenberger, J Bojunga, et al.
Alimentary Pharmacology & Therapeutics
|
June 20, 2017
No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort
V T Mücke, M M Mücke, K-H Peiffer, et al.
Journal of Viral Hepatitis
|
August 9, 2016
Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy
V Knop, D Hoppe, T Welzel, et al.
Medical Microbiology and Immunology
|
December 16, 2015
Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment
F Wiesmann, G Naeth, A Berger, et al.
Page
of 11